| Bioactivity | RGDV is a platelet aggregation inhibitor. RGDV inhibits platelet-dependent thrombus formation. RGDV is used for tumor recognition via the targeting effect[1][2]. |
| Invitro | RGDV (25-100 nM; thrombus vessel model) selectively inhibits platelet-dependent thrombus formation and decreases the accumulation of both platelets and fibrin on the collagen substrate in a dose-response manner[1]. |
| Name | RGDV |
| CAS | 93674-99-8 |
| Shortening | RGDV |
| Formula | C17H31N7O7 |
| Molar Mass | 445.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |